Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 4, 2007
18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases
Christopher C Riedl, Timothy Akhurst, Steven Larson, et al.
Journal of Medical Imaging and Radiation Oncology
|
August 26, 2021
The predictive value of PET/CT for distant recurrences in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
Joseph C Kong, Jennifer Ryan, Timothy Akhurst, et al.
The Annals of Thoracic Surgery
|
January 23, 2016
Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer
Stephen A Barnett, Robert J Downey, Junting Zheng, et al.
Urology
|
May 29, 2002
Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer
Michael J Morris, Timothy Akhurst, Iman Osman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2005
Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases
Timothy Akhurst, Tara J Kates, Madhu Mazumdar, et al.
Asia-Pacific Journal of Clinical Oncology
|
February 8, 2020
The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose (<sup>18</sup> F) positron-emission tomography positive intermediate grade pancreatic neuroendocrine tumors
Mei Sim Lung, Rodney J Hicks, Nick Pavlakis, et al.
Journal of the American College of Surgeons
|
June 26, 2004
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer
Jose G Guillem, Harvey G Moore, Timothy Akhurst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 7, 2002
Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression
Juri Gelovani Tjuvajev, Mikhail Doubrovin, Timothy Akhurst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2008
Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy
Tobias Leibold, Jinru Shia, Leyo Ruo, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T
|
October 1, 2003
Differential Metabolism and Pharmacokinetics of L-[1-(11)C]-Methionine and 2-[(18)F] Fluoro-2-deoxy-D-glucose (FDG) in Androgen Independent Prostate Cancer
Homer A. Macapinlac, John L. Humm, Timothy Akhurst, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 4, 2007
18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases
Christopher C Riedl, Timothy Akhurst, Steven Larson, et al.
Journal of Medical Imaging and Radiation Oncology
|
August 26, 2021
The predictive value of PET/CT for distant recurrences in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
Joseph C Kong, Jennifer Ryan, Timothy Akhurst, et al.
The Annals of Thoracic Surgery
|
January 23, 2016
Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer
Stephen A Barnett, Robert J Downey, Junting Zheng, et al.
Urology
|
May 29, 2002
Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer
Michael J Morris, Timothy Akhurst, Iman Osman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2005
Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases
Timothy Akhurst, Tara J Kates, Madhu Mazumdar, et al.
Asia-Pacific Journal of Clinical Oncology
|
February 8, 2020
The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose (<sup>18</sup> F) positron-emission tomography positive intermediate grade pancreatic neuroendocrine tumors
Mei Sim Lung, Rodney J Hicks, Nick Pavlakis, et al.
Journal of the American College of Surgeons
|
June 26, 2004
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer
Jose G Guillem, Harvey G Moore, Timothy Akhurst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 7, 2002
Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression
Juri Gelovani Tjuvajev, Mikhail Doubrovin, Timothy Akhurst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2008
Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy
Tobias Leibold, Jinru Shia, Leyo Ruo, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T
|
October 1, 2003
Differential Metabolism and Pharmacokinetics of L-[1-(11)C]-Methionine and 2-[(18)F] Fluoro-2-deoxy-D-glucose (FDG) in Androgen Independent Prostate Cancer
Homer A. Macapinlac, John L. Humm, Timothy Akhurst, et al.
Page
of 4